OPNT Annual Working Capital
$62.31 M
+$9.63 M+18.29%
31 December 2021
Summary:
As of February 5, 2025, OPNT annual working capital is $62.31 million, with the most recent change of +$9.63 million (+18.29%) on December 31, 2021. During the last 3 years, it has risen by +$42.77 million (+218.84%).OPNT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Quarterly Working Capital
$31.51 M
-$11.26 M-26.32%
30 September 2022
Summary:
As of February 5, 2025, OPNT quarterly working capital is $31.51 million, with the most recent change of -$11.26 million (-26.32%) on September 30, 2022. Over the past year, it has dropped by -$29.02 million (-47.94%).OPNT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.3% | -47.9% |
| 3 y3 years | +218.8% | +2.2% |
| 5 y5 years | +312.7% | +1197.2% |
OPNT Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -49.4% |
Opiant Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $31.51 M(-26.3%) |
| June 2022 | - | $42.76 M(-18.3%) |
| Mar 2022 | - | $52.37 M(-16.0%) |
| Dec 2021 | $62.31 M(+18.3%) | $62.31 M(+3.0%) |
| Sept 2021 | - | $60.52 M(+10.6%) |
| June 2021 | - | $54.73 M(+9.6%) |
| Mar 2021 | - | $49.96 M(-5.2%) |
| Dec 2020 | $52.68 M(+56.6%) | $52.68 M(+55.5%) |
| Sept 2020 | - | $33.88 M(+0.9%) |
| June 2020 | - | $33.58 M(+1.4%) |
| Mar 2020 | - | $33.10 M(-1.6%) |
| Dec 2019 | $33.64 M(+72.2%) | $33.64 M(+9.1%) |
| Sept 2019 | - | $30.83 M(+54.2%) |
| June 2019 | - | $19.99 M(+19.2%) |
| Mar 2019 | - | $16.77 M(-14.2%) |
| Dec 2018 | $19.54 M(+29.4%) | $19.54 M(-23.5%) |
| Sept 2018 | - | $25.56 M(+144.8%) |
| June 2018 | - | $10.44 M(+29.3%) |
| Mar 2018 | - | $8.08 M(+232.5%) |
| Dec 2017 | $15.10 M(+128.0%) | - |
| Oct 2017 | - | $2.43 M(-63.3%) |
| July 2017 | $6.62 M(-378.1%) | $6.62 M(-0.5%) |
| Apr 2017 | - | $6.65 M(-14.5%) |
| Jan 2017 | - | $7.78 M(-378.0%) |
| Oct 2016 | - | -$2.80 M(+17.6%) |
| July 2016 | -$2.38 M(-23.4%) | -$2.38 M(+44.0%) |
| Apr 2016 | - | -$1.65 M(-36.2%) |
| Jan 2016 | - | -$2.59 M(-22.0%) |
| Oct 2015 | - | -$3.32 M(+6.8%) |
| July 2015 | -$3.11 M | -$3.11 M(+189.3%) |
| Apr 2015 | - | -$1.07 M(-11.2%) |
| Jan 2015 | - | -$1.21 M(+220.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2014 | - | -$377.80 K(-77.6%) |
| July 2014 | -$1.69 M(+541.5%) | -$1.69 M(+32.1%) |
| Apr 2014 | - | -$1.28 M(+77.4%) |
| Jan 2014 | - | -$720.80 K(-35.3%) |
| Oct 2013 | - | -$1.11 M(+323.4%) |
| July 2013 | -$263.20 K(-59.1%) | -$263.20 K(-28.1%) |
| Apr 2013 | - | -$366.00 K(-53.6%) |
| Jan 2013 | - | -$788.40 K(-8.7%) |
| Oct 2012 | - | -$863.30 K(+34.2%) |
| July 2012 | -$643.30 K(+76.5%) | -$643.30 K(+26.4%) |
| Apr 2012 | - | -$508.80 K(+58.7%) |
| Jan 2012 | - | -$320.70 K(+24.7%) |
| Oct 2011 | - | -$257.10 K(-29.4%) |
| July 2011 | -$364.40 K(+31.8%) | -$364.40 K(+24.9%) |
| Apr 2011 | - | -$291.80 K(-55.2%) |
| Jan 2011 | - | -$651.80 K(-27.3%) |
| Oct 2010 | - | -$896.60 K(+224.3%) |
| July 2010 | -$276.50 K(<-9900.0%) | -$276.50 K(-41.5%) |
| Apr 2010 | - | -$473.00 K(+84.8%) |
| Jan 2010 | - | -$255.90 K(+238.5%) |
| Oct 2009 | - | -$75.60 K(<-9900.0%) |
| July 2009 | $300.00(-101.1%) | $300.00(-100.7%) |
| Apr 2009 | - | -$41.20 K(+12.0%) |
| Jan 2009 | - | -$36.80 K(+9.9%) |
| Oct 2008 | - | -$33.50 K(+18.8%) |
| July 2008 | -$28.20 K(+176.5%) | -$28.20 K(+75.2%) |
| Apr 2008 | - | -$16.10 K(+12.6%) |
| Jan 2008 | - | -$14.30 K(+31.2%) |
| Oct 2007 | - | -$10.90 K(+6.9%) |
| July 2007 | -$10.20 K | -$10.20 K(-636.8%) |
| Apr 2007 | - | $1900.00(-86.8%) |
| Jan 2007 | - | $14.40 K |
FAQ
- What is Opiant Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual working capital year-on-year change?
- What is Opiant Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly working capital year-on-year change?
What is Opiant Pharmaceuticals annual working capital?
The current annual working capital of OPNT is $62.31 M
What is the all time high annual working capital for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual working capital is $62.31 M
What is Opiant Pharmaceuticals annual working capital year-on-year change?
Over the past year, OPNT annual working capital has changed by +$9.63 M (+18.29%)
What is Opiant Pharmaceuticals quarterly working capital?
The current quarterly working capital of OPNT is $31.51 M
What is the all time high quarterly working capital for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly working capital is $62.31 M
What is Opiant Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, OPNT quarterly working capital has changed by -$29.02 M (-47.94%)